YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
NEW YORK, Feb. 25, 2023 (GLOBE NEWSWIRE) -- First Miami Bancorp, Inc. (OTC: FMIA) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of FMIA to United Community Banks, Inc. for…
NEW YORK, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston filed the first class action lawsuit against Kiromic BioPharma, Inc. (“Kiromic” or the “Company”) (NASDAQ: KRBP) and against certain officers and directors of the Compan…
RADNOR, Pa., Oct. 03, 2022 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern D…
NEW YORK, Oct. 02, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Coinbase Global, Inc. (NASD…
SAN FRANCISCO, Oct. 02, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Kiromic BioPharma, Inc. (NASDAQ: KRBP) investors who purchased Kiromic shares to submit your losses now. Class Period: June 25, 2021 – Aug. 13, 2021 Lead Plaintiff Deadli…
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kiromic BioPharma, Inc. (NASDAQ: KRBP): (i) pursuant and/or traceable to the offering documents is…
NEW YORK, Sept. 28, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kiromic BioPharma, Inc. (NASDAQ: KRBP): (i) pursuant and/or traceable to the offering documents is…
RADNOR, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern…
NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kiromic BioPharma Inc. (“Kiromic” or the “Company”) (NASDAQ: KRBP). Such investors are advised to contact Robert S. Willoughby at…
SAN FRANCISCO , Sept. 27, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Kiromic BioPharma, Inc. (NASDAQ: KRBP) investors who purchased Kiromic shares to submit your losses now. Class Period: June 25, 2021 – Aug. 13, 2021 Lead Plaintiff Dead…
NEW YORK, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Kiromic BioPharma, Inc. (N…
SAN FRANCISCO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Kiromic BioPharma, Inc. (NASDAQ: KRBP) investors who purchased Kiromic shares to submit your losses now. Class Period: June 25, 2021 – Aug. 13, 2021 Lead Plaintiff Deadl…
NEW YORK, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of…
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Carvana Co. (NYSE: CVNA),…
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kiromic BioPharma Inc. (“Kiromic” or the “Company”) (NASDAQ: KRBP). Such investors are advised to contact Robert S. Willoughby at…
NEW YORK, Sept. 19, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kiromic BioPharma, Inc. (NASDAQ: KRBP): (i) pursuant and/or traceable to the offering documents is…
RADNOR, Pa., Sept. 19, 2022 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern…
SAN FRANCISCO, Sept. 17, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Kiromic BioPharma, Inc. (NASDAQ: KRBP) investors who purchased Kiromic shares to submit your losses now. Class Period: June 25, 2021 – Aug. 13, 2021 Lead Plaintiff Deadl…
NEW YORK, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Carvana Co. (NYSE: CVNA),…
NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kiromic BioPharma Inc. (“Kiromic” or the “Company”) (NASDAQ: KRBP). Such investors are advised to contact Robert S. Willoughby at…
NEW YORK, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston is the only firm that filed a class action lawsuit against Kiromic BioPharma, Inc. (“Kiromic” or the “Company”) (NASDAQ: KRBP) and against certain officers and director…
NEW YORK, Sept. 13, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kiromic BioPharma, Inc. (NASDAQ: KRBP): (i) pursuant and/or traceable to the offering documents is…
SAN FRANCISCO, Sept. 12, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Kiromic BioPharma, Inc. (NASDAQ: KRBP) investors who purchased Kiromic shares to submit your losses now. Class Period: June 25, 2021 – Aug. 13, 2021 Lead Plaintiff Deadl…
NEW YORK, Sept. 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Kiromic BioPharma, Inc. (N…
RADNOR, Pa., Sept. 11, 2022 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern…
NEW YORK, Sept. 09, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kiromic BioPharma, Inc. (NASDAQ: KRBP): (i) pursuant and/or traceable to the offering documents is…
NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Weber, Inc. (NYSE: WEBR),…
SAN FRANCISCO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Kiromic BioPharma, Inc. (NASDAQ: KRBP) investors who purchased Kiromic shares to submit your losses now. Class Period: June 25, 2021 – Aug. 13, 2021 Lead Plaintiff Deadl…
NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kiromic BioPharma Inc. (“Kiromic” or the “Company”) (NASDAQ: KRBP). Such investors are advised to contact Robert S. Willoughby at…
紐約, Sept. 05, 2022 (GLOBE NEWSWIRE) -- 為何︰全球投資者權益律師事務所 Rosen Law Firm 提醒在下述情況購買 Kiromic BioPharma, Inc. (NASDAQ: KRBP) 證券的人士：(i) 根據及／或可追溯至與公司於 2021 年 7 月 2 日或前後進行的首次公開招股（「IPO」）有關的發行文件；及／或 (ii) 在 2021 年 6 月 25 日至 2021 年 8 月 13 日（包括首尾兩日）期間（「…
NEW YORK, Sept. 04, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Kiromic BioPharma, Inc. (NASDAQ: KRBP): (i) pursuant and/or traceable to the offering documents is…
RADNOR, Pa., Sept. 03, 2022 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Southern…
NEW YORK, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of…
NEW YORK, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kiromic BioPharma Inc. (“Kiromic” or the “Company”) (NASDAQ: KRBP). Such investors are advised to contact Robert S. Willoughby at n…
紐約, Aug. 30, 2022 (GLOBE NEWSWIRE) -- 為何︰全球投資者權益律師事務所 Rosen Law Firm 提醒在下述情況購買 Kiromic BioPharma, Inc. (NASDAQ: KRBP) 證券的人士：(i) 根據及／或可追溯至與公司於 2021 年 7 月 2 日或前後進行的首次公開招（「IPO」）有關的發行文件；及／或 (ii) 在 2021 年 6 月 25 日至 2021 年 8 月 13 日（包括首尾兩日）期間（「集體…
SAN FRANCISCO, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Kiromic BioPharma, Inc. (NASDAQ: KRBP) investors who purchased Kiromic shares to submit your losses now. Class Period: June 25, 2021 – Aug. 13, 2021 Lead Plaintiff Deadli…